Scientia Vascular Announces $14 Million Growth Financing Led by Piper Sandler Merchant Banking
Scientia Vascular, a leader in neurovascular innovation, has secured $14 million in growth financing led by Piper Sandler Merchant Banking.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Scientia Vascular, a leader in neurovascular innovation, has secured $14 million in growth financing led by Piper Sandler Merchant Banking. This funding will support Scientia's ongoing commercialization of advanced neurovascular tools, enhancing treatment options for various cerebral vascular diseases. The company is known for its microfabrication technology, offering a comprehensive portfolio of neurovascular guidewires and developing highly differentiated micro and aspiration catheters.
Scientia recently launched its Plato 17 and Socrates 38 neurovascular catheters. The investment from Piper Sandler Merchant Banking aims to accelerate Scientia's growth and further its mission of developing state-of-the-art technology for patients with unmet needs. This partnership aligns with Piper Sandler's strategy of investing in companies with strong teams, innovative technology, and significant market opportunities.
Positive
- Secured $14 million in growth financing led by Piper Sandler Merchant Banking
- Commercializing next-generation neurovascular tools for various disease states
- Offers the most comprehensive portfolio of neurovascular guidewires in the market
- Recently launched Plato 17 and Socrates 38 neurovascular catheters
- Strong financial performance noted by investor
Negative
- None.
Details
News Market Reaction – PIPR
The recorded move for PIPR in the trading session of this news was +0.88%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Through cutting-edge innovation, Scientia is advancing the way diseases of the cerebral vasculature are treated. Renowned for disrupting the industry with microfabrication, Scientia currently offers the most comprehensive portfolio of neurovascular guidewires on the market and has applied the same groundbreaking technologies, design principles, and precision machinery to develop highly differentiated micro catheters and aspiration catheters. As Scientia moves ahead, microfabrication will continue to serve as the platform for innovating technologies that address a wide array of neurovascular disease states more effectively.
Tom Schnettler, managing director at Piper Sandler Merchant Banking, said, "Scientia exemplifies many of the attributes we look for in an investment partner: a strong team with a long track record of innovation and success, differentiated and groundbreaking technology that improves patient outcomes, a large and growing market opportunity and strong financial performance. We look forward to partnering with John Lippert and the rest of the team at Scientia to support the next stage of the company's growth."
"Our mission at Scientia is to develop and apply state-of-the-art technology to care for patients with unmet needs. We are grateful for the support of Piper Sandler Merchant Banking as we look to accelerate our growth following the launch of our Plato 17 and Socrates 38 neurovascular catheters," said John Lippert, founder and CEO of Scientia.
About Scientia Vascular:
Scientia Vascular is committed to enhancing patient care through innovative medical devices. With a focus on neurovascular advancements, Scientia Vascular remains at the forefront of technological breakthroughs in the medical field.
About Piper Sandler Merchant Banking:
Piper Sandler Merchant Banking (PSMB) is the growth equity investment arm of Piper Sandler Companies (NYSE: PIPR). The PSMB team strives to partner with founders and CEOs of growing, commercial stage businesses that can benefit by leveraging Piper Sandler's knowledge, experience, capital and relationships to build market leading enterprises. PSMB provides investment advisory services through the affiliated registered investment adviser, PSC Capital Partners LLC. Learn more about Piper Sandler Merchant Banking.
For more information, contact:
Larry Myres
President
Scientia Vascular, Inc.
Larry.myres@scientiavascular.com
760.889.4649
View original content to download multimedia:https://www.prnewswire.com/news-releases/scientia-vascular-announces-14-million-growth-financing-led-by-piper-sandler-merchant-banking-302239766.html
SOURCE Scientia Vascular
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.